Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab.

Voss M, Batarfi A, Steidl E, Wagner M, Forster MT, Steinbach JP, Rödel CM, Bojunga J, Ronellenfitsch MW.

J Clin Med. 2019 Oct 3;8(10). pii: E1608. doi: 10.3390/jcm8101608.

2.

Reply to A. Abdalla et al.

Fokas E, Rödel C; German Rectal Cancer Study Group.

J Clin Oncol. 2019 Oct 9:JCO1902179. doi: 10.1200/JCO.19.02179. [Epub ahead of print] No abstract available.

PMID:
31596636
3.

Blood Flow Suppresses Vascular Anomalies in a Zebrafish Model of Cerebral Cavernous Malformations.

Rödel CJ, Otten C, Donat S, Lourenço M, Fischer D, Kuropka B, Paolini A, Freund C, Abdelilah-Seyfried S.

Circ Res. 2019 Oct 25;125(10):e43-e54. doi: 10.1161/CIRCRESAHA.119.315076. Epub 2019 Sep 9.

PMID:
31495257
4.

Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy.

Fleischmann M, Martin D, Peña-Llopis S, Oppermann J, von der Grün J, Diefenhardt M, Chatzikonstantinou G, Fokas E, Rödel C, Strebhardt K, Becker S, Rödel F, Tselis N.

Front Oncol. 2019 Aug 14;9:742. doi: 10.3389/fonc.2019.00742. eCollection 2019.

5.

The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper.

Valentini V, Marijnen C, Beets G, Bujko K, De Bari B, Cervantes A, Chiloiro G, Coco C, Gambacorta MA, Glynne-Jones R, Haustermans K, Meldolesi E, Peters F, Rödel C, Rutten H, van de Velde C, Aristei C.

Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)32980-9. doi: 10.1016/j.radonc.2019.07.001. [Epub ahead of print]

PMID:
31431374
6.

Characterization of the tumor immune micromilieu and its interference with outcome after concurrent chemoradiation in patients with oropharyngeal carcinomas.

Hess AK, Jöhrens K, Zakarneh A, Balermpas P, Von Der Grün J, Rödel C, Weichert W, Hummel M, Keilholz U, Budach V, Tinhofer I.

Oncoimmunology. 2019 May 25;8(8):1614858. doi: 10.1080/2162402X.2019.1614858. eCollection 2019.

PMID:
31413922
7.

Sex-Based Disparities Among Cancer Clinical Trial Participants.

Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, Jagsi R, Gomez DR, Minsky BD, Rödel C, Fokas E.

J Natl Cancer Inst. 2019 Jul 27. pii: djz154. doi: 10.1093/jnci/djz154. [Epub ahead of print]

PMID:
31350545
8.

Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2).

Merten R, Ott O, Haderlein M, Bertz S, Hartmann A, Wullich B, Keck B, Kühn R, Rödel CM, Weiss C, Gall C, Uter W, Fietkau R.

Oncologist. 2019 Jul 10. pii: theoncologist.2018-0280. doi: 10.1634/theoncologist.2018-0280. [Epub ahead of print]

PMID:
31292267
9.

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.

Fokas E, Allgäuer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Schmiegel W, Jacobasch L, Weitz J, Folprecht G, Schlenska-Lange A, Flentje M, Germer CT, Grützmann R, Schwarzbach M, Paolucci V, Bechstein WO, Friede T, Ghadimi M, Hofheinz RD, Rödel C; German Rectal Cancer Study Group.

J Clin Oncol. 2019 May 31:JCO1900308. doi: 10.1200/JCO.19.00308. [Epub ahead of print]

PMID:
31150315
10.

Organ Preservation in Rectal Cancer: The Patients' Perspective.

Gani C, Gani N, Zschaeck S, Eberle F, Schaeffeler N, Hehr T, Berger B, Fischer SG, Claßen J, Zipfel S, Rödel C, Teufel M, Zips D.

Front Oncol. 2019 May 10;9:318. doi: 10.3389/fonc.2019.00318. eCollection 2019.

11.

Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?

von der Grün J, Rödel F, Brandts C, Fokas E, Guckenberger M, Rödel C, Balermpas P.

Cancers (Basel). 2019 Apr 3;11(4). pii: E472. doi: 10.3390/cancers11040472. Review.

12.

Chemoradiotherapy for anal cancer: are we as good as we think?

Martin D, Rödel C, Fokas E.

Strahlenther Onkol. 2019 May;195(5):369-373. doi: 10.1007/s00066-019-01444-7. Epub 2019 Apr 1. Review.

PMID:
30937508
13.

Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial.

Diefenhardt M, Hofheinz RD, Martin D, Beißbarth T, Arnold D, Hartmann A, von der Grün J, Grützmann R, Liersch T, Ströbel P, Grabenbauer GG, Rieger M, Fietkau R, Graeven U, Weitz J, Folprecht G, Ghadimi M, Rödel F, Rödel C, Fokas E; German Rectal Cancer Study Group.

Int J Cancer. 2019 Oct 15;145(8):2282-2291. doi: 10.1002/ijc.32274. Epub 2019 Apr 2.

PMID:
30868576
14.

A high resolution extreme ultraviolet spectrometer system optimized for harmonic spectroscopy and XUV beam analysis.

Wünsche M, Fuchs S, Weber T, Nathanael J, Abel JJ, Reinhard J, Wiesner F, Hübner U, Skruszewicz SJ, Paulus GG, Rödel C.

Rev Sci Instrum. 2019 Feb;90(2):023108. doi: 10.1063/1.5054116.

PMID:
30831726
15.

Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma.

Stera S, Balermpas P, Blanck O, Wolff R, Wurster S, Baumann R, Szücs M, Loutfi-Krauss B, Wilhelm ML, Seifert V, Rades D, Rödel C, Dunst J, Hildebrandt G, Arnold A, Meissner M, Kähler KC.

Melanoma Res. 2019 Apr;29(2):187-195. doi: 10.1097/CMR.0000000000000542.

PMID:
30802230
16.

Merkel Cell Polyoma Viral Load and Intratumoral CD8+ Lymphocyte Infiltration Predict Overall Survival in Patients With Merkel Cell Carcinoma.

von der Grün J, Winkelmann R, Meissner M, Wieland U, Silling S, Martin D, Fokas E, Rödel C, Rödel F, Balermpas P.

Front Oncol. 2019 Jan 24;9:20. doi: 10.3389/fonc.2019.00020. eCollection 2019.

17.

Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy.

Rödel F, Martin D, Balermpas P, Wieland U, Winkelmann R, Riekmann T, Falk S, Rödel C, Fokas E.

Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):126-137. doi: 10.1016/j.bbcan.2018.12.006. Epub 2018 Dec 31. Review.

PMID:
30605716
18.

Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2max ) of >180 Gy for patients with recurrent head and neck cancer.

von der Grün J, Köhn J, Loutfi-Krauss B, Blanck O, Rödel C, Balermpas P.

Head Neck. 2019 Apr;41(4):E48-E54. doi: 10.1002/hed.25428. Epub 2018 Dec 6.

PMID:
30521102
19.

CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.

Chatzikonstantinou G, Zamboglou N, Archavlis E, Strouthos I, Zoga E, Milickovic N, Hilaris B, Baltas D, Rödel C, Tselis N.

Strahlenther Onkol. 2018 Dec;194(12):1171-1179. doi: 10.1007/s00066-018-1358-3. Epub 2018 Sep 10.

PMID:
30203110
20.

A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection.

Hess J, Unger K, Maihoefer C, Schüttrumpf L, Wintergerst L, Heider T, Weber P, Marschner S, Braselmann H, Samaga D, Kuger S, Pflugradt U, Baumeister P, Walch A, Woischke C, Kirchner T, Werner M, Werner K, Baumann M, Budach V, Combs SE, Debus J, Grosu AL, Krause M, Linge A, Rödel C, Stuschke M, Zips D, Zitzelsberger H, Ganswindt U, Henke M, Belka C.

Clin Cancer Res. 2019 Mar 1;25(5):1505-1516. doi: 10.1158/1078-0432.CCR-18-0776. Epub 2018 Aug 31.

PMID:
30171046
21.

Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib.

Hehlgans S, Booms P, Güllülü Ö, Sader R, Rödel C, Balermpas P, Rödel F, Ghanaati S.

Int J Mol Sci. 2018 Aug 23;19(9). pii: E2485. doi: 10.3390/ijms19092485.

22.

The CCM1-CCM2 complex controls complementary functions of ROCK1 and ROCK2 that are required for endothelial integrity.

Lisowska J, Rödel CJ, Manet S, Miroshnikova YA, Boyault C, Planus E, De Mets R, Lee HH, Destaing O, Mertani H, Boulday G, Tournier-Lasserve E, Balland M, Abdelilah-Seyfried S, Albiges-Rizo C, Faurobert E.

J Cell Sci. 2018 Aug 13;131(15). pii: jcs216093. doi: 10.1242/jcs.216093.

23.

Cost analysis of a wait-and-see strategy after radiochemotherapy in distal rectal cancer.

Gani C, Grosse U, Clasen S, Kirschniak A, Goetz M, Rödel C, Zips D.

Strahlenther Onkol. 2018 Nov;194(11):985-990. doi: 10.1007/s00066-018-1327-x. Epub 2018 Jul 9.

PMID:
29987338
24.

Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials.

von den Grün JM, Hartmann A, Fietkau R, Ghadimi M, Liersch T, Hohenberger W, Weitz J, Sauer R, Wittekind C, Ströbel P, Rödel C, Fokas E; German Rectal Cancer Study Group.

Radiother Oncol. 2018 Sep;128(3):557-563. doi: 10.1016/j.radonc.2018.06.008. Epub 2018 Jun 18.

PMID:
29929861
25.

Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.

Kitz J, Fokas E, Beissbarth T, Ströbel P, Wittekind C, Hartmann A, Rüschoff J, Papadopoulos T, Rösler E, Ortloff-Kittredge P, Kania U, Schlitt H, Link KH, Bechstein W, Raab HR, Staib L, Germer CT, Liersch T, Sauer R, Rödel C, Ghadimi M, Hohenberger W; German Rectal Cancer Study Group.

JAMA Surg. 2018 Aug 1;153(8):e181607. doi: 10.1001/jamasurg.2018.1607. Epub 2018 Aug 15.

26.

Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.

Balermpas P, Stera S, Müller von der Grün J, Loutfi-Krauss B, Forster MT, Wagner M, Keller C, Rödel C, Seifert V, Blanck O, Wolff R.

PLoS One. 2018 Jun 6;13(6):e0198692. doi: 10.1371/journal.pone.0198692. eCollection 2018.

27.

Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trial.

Hofheinz RD, Arnold D, Fokas E, Kaufmann M, Hothorn T, Folprecht G, Fietkau R, Hohenberger W, Ghadimi M, Liersch T, Grabenbauer GG, Sauer R, Rödel C, Graeven U; German Rectal Cancer Study Group.

Ann Oncol. 2018 Aug 1;29(8):1793-1799. doi: 10.1093/annonc/mdy205.

PMID:
29873684
28.

Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors.

Baumann R, Chan MKH, Pyschny F, Stera S, Malzkuhn B, Wurster S, Huttenlocher S, Szücs M, Imhoff D, Keller C, Balermpas P, Rades D, Rödel C, Dunst J, Hildebrandt G, Blanck O.

Front Oncol. 2018 May 17;8:171. doi: 10.3389/fonc.2018.00171. eCollection 2018.

29.

Long-term prognostic impact of surgical complications in the German Rectal Cancer Trial CAO/ARO/AIO-94.

Sprenger T, Beißbarth T, Sauer R, Tschmelitsch J, Fietkau R, Liersch T, Hohenberger W, Staib L, Gaedcke J, Raab HR, Rödel C, Ghadimi M.

Br J Surg. 2018 Oct;105(11):1510-1518. doi: 10.1002/bjs.10877. Epub 2018 May 30.

PMID:
29846017
30.

Treatment planning for spinal radiosurgery : A competitive multiplatform benchmark challenge.

Moustakis C, Chan MKH, Kim J, Nilsson J, Bergman A, Bichay TJ, Palazon Cano I, Cilla S, Deodato F, Doro R, Dunst J, Eich HT, Fau P, Fong M, Haverkamp U, Heinze S, Hildebrandt G, Imhoff D, de Klerck E, Köhn J, Lambrecht U, Loutfi-Krauss B, Ebrahimi F, Masi L, Mayville AH, Mestrovic A, Milder M, Morganti AG, Rades D, Ramm U, Rödel C, Siebert FA, den Toom W, Wang L, Wurster S, Schweikard A, Soltys SG, Ryu S, Blanck O.

Strahlenther Onkol. 2018 Sep;194(9):843-854. doi: 10.1007/s00066-018-1314-2. Epub 2018 May 25.

PMID:
29802435
31.

Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer.

Strouthos I, Chatzikonstantinou G, Zamboglou N, Milickovic N, Papaioannou S, Bon D, Zamboglou C, Rödel C, Baltas D, Tselis N.

Radiother Oncol. 2018 Aug;128(2):301-307. doi: 10.1016/j.radonc.2018.04.031. Epub 2018 May 12.

PMID:
29764692
32.

Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO).

Müller von der Grün J, Bon D, Rödel C, Balermpas P.

Strahlenther Onkol. 2018 Aug;194(8):750-758. doi: 10.1007/s00066-018-1308-0. Epub 2018 May 14.

PMID:
29761228
33.

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D; ESMO Guidelines Committee.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv263. doi: 10.1093/annonc/mdy161. No abstract available.

PMID:
29741565
34.

Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial.

Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grützmann R, Ghadimi M, Liersch T, Ströbel P, Grabenbauer GG, Graeven U, Hofheinz RD, Köhne CH, Wittekind C, Sauer R, Kaufmann M, Hothorn T, Rödel C; German Rectal Cancer Study Group.

Ann Oncol. 2018 Jul 1;29(7):1521-1527. doi: 10.1093/annonc/mdy143.

PMID:
29718095
35.

Organ preservation in rectal cancer - Challenges and future strategies.

Gani C, Bonomo P, Zwirner K, Schroeder C, Menegakis A, Rödel C, Zips D.

Clin Transl Radiat Oncol. 2017 Mar 23;3:9-15. doi: 10.1016/j.ctro.2017.02.002. eCollection 2017 Apr. Review.

36.

[Radiochemotherapy for invasive bladder cancer : An update].

Tselis N, Prott FJ, Ott O, Weiss C, Rödel C.

Urologe A. 2018 Jun;57(6):679-685. doi: 10.1007/s00120-018-0628-0. Review. German.

PMID:
29651707
37.

SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy.

De-Colle C, Mönnich D, Welz S, Boeke S, Sipos B, Fend F, Mauz PS, Tinhofer I, Budach V, Jawad JA, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Bayer C, Belka C, Pigorsch S, Combs SE, Lohaus F, Linge A, Krause M, Baumann M, Zips D, Menegakis A.

Clin Transl Radiat Oncol. 2017 Jul 14;5:28-36. doi: 10.1016/j.ctro.2017.06.004. eCollection 2017 Aug.

38.

Chemoradiotherapy as Definitive Treatment for Elderly Patients with Head and Neck Cancer.

Müller von der Grün J, Martin D, Stöver T, Ghanaati S, Rödel C, Balermpas P.

Biomed Res Int. 2018 Jan 17;2018:3508795. doi: 10.1155/2018/3508795. eCollection 2018.

39.

Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK).

Combs SE, Niyazi M, Adeberg S, Bougatf N, Kaul D, Fleischmann DF, Gruen A, Fokas E, Rödel CM, Eckert F, Paulsen F, Oehlke O, Grosu AL, Seidlitz A, Lattermann A, Krause M, Baumann M, Guberina M, Stuschke M, Budach V, Belka C, Debus J, Kessel KA.

Cancer Med. 2018 May;7(5):1742-1749. doi: 10.1002/cam4.1425. Epub 2018 Mar 23.

40.

A sensitive EUV Schwarzschild microscope for plasma studies with sub-micrometer resolution.

Zastrau U, Rödel C, Nakatsutsumi M, Feigl T, Appel K, Chen B, Döppner T, Fennel T, Fiedler T, Fletcher LB, Förster E, Gamboa E, Gericke DO, Göde S, Grote-Fortmann C, Hilbert V, Kazak L, Laarmann T, Lee HJ, Mabey P, Martinez F, Meiwes-Broer KH, Pauer H, Perske M, Przystawik A, Roling S, Skruszewicz S, Shihab M, Tiggesbäumker J, Toleikis S, Wünsche M, Zacharias H, Glenzer SH, Gregori G.

Rev Sci Instrum. 2018 Feb;89(2):023703. doi: 10.1063/1.5007950.

PMID:
29495844
41.

Anal squamous cell carcinoma - State of the art management and future perspectives.

Martin D, Balermpas P, Winkelmann R, Rödel F, Rödel C, Fokas E.

Cancer Treat Rev. 2018 Apr;65:11-21. doi: 10.1016/j.ctrv.2018.02.001. Epub 2018 Feb 22. Review.

PMID:
29494827
42.

Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis.

Niyazi M, Adeberg S, Kaul D, Boulesteix AL, Bougatf N, Fleischmann DF, Grün A, Krämer A, Rödel C, Eckert F, Paulsen F, Kessel KA, Combs SE, Oehlke O, Grosu AL, Seidlitz A, Lattermann A, Krause M, Baumann M, Guberina M, Stuschke M, Budach V, Belka C, Debus J.

Radiother Oncol. 2018 Apr;127(1):121-127. doi: 10.1016/j.radonc.2018.01.011. Epub 2018 Feb 9.

PMID:
29433917
43.

[Nivolumab for pretreated metastatic anal cancer : Immune checkpoint blockade is also advised in combination with radiochemotherapy].

Martin D, Rödel C, Fokas E.

Strahlenther Onkol. 2018 Apr;194(4):356-357. doi: 10.1007/s00066-018-1272-8. German. No abstract available.

PMID:
29392353
44.

Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy.

Schmidt S, Linge A, Zwanenburg A, Leger S, Lohaus F, Krenn C, Appold S, Gudziol V, Nowak A, von Neubeck C, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Bunea H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Baumann M, Krause M, Löck S; DKTK-ROG.

Clin Cancer Res. 2018 Mar 15;24(6):1364-1374. doi: 10.1158/1078-0432.CCR-17-2345. Epub 2018 Jan 3.

45.

Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.

Linge A, Schötz U, Löck S, Lohaus F, von Neubeck C, Gudziol V, Nowak A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Bunea H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Lauber K, Pigorsch S, Combs SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Krause M, Belka C, Baumann M; DKTK-ROG.

Radiother Oncol. 2018 Apr;127(1):27-35. doi: 10.1016/j.radonc.2017.12.007. Epub 2017 Dec 30.

PMID:
29295747
46.

Complete response after chemoradiotherapy for rectal cancer: what is the reasonable approach?

Rödel C, Fokas E, Gani C.

Innov Surg Sci. 2017 Dec 28;3(1):47-53. doi: 10.1515/iss-2017-0041. eCollection 2018 Mar. Review.

47.

Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Stangl S, Tontcheva N, Sievert W, Shevtsov M, Niu M, Schmid TE, Pigorsch S, Combs SE, Haller B, Balermpas P, Rödel F, Rödel C, Fokas E, Krause M, Linge A, Lohaus F, Baumann M, Tinhofer I, Budach V, Stuschke M, Grosu AL, Abdollahi A, Debus J, Belka C, Maihöfer C, Mönnich D, Zips D, Multhoff G.

Int J Cancer. 2018 May 1;142(9):1911-1925. doi: 10.1002/ijc.31213. Epub 2017 Dec 23.

48.

S3-Leitlinie – Kolorektales Karzinom.

Schmiegel W, Buchberger B, Follmann M, Graeven U, Heinemann V, Langer T, Nothacker M, Porschen R, Rödel C, Rösch T, Schmitt W, Wesselmann S, Pox C.

Z Gastroenterol. 2017 Dec;55(12):1344-1498. doi: 10.1055/s-0043-121106. Epub 2017 Dec 6. German. No abstract available.

PMID:
29212104
Free Article
49.

Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer.

Fokas E, Ströbel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer GG, Hartmann A, Kaufmann M, Sauer R, Graeven U, Hoffmanns H, Raab HR, Hothorn T, Wittekind C, Rödel C; German Rectal Cancer Study Group.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx095.

PMID:
29206996
50.

Prognostic impact of RITA expression in patients with anal squamous cell carcinoma treated with chemoradiotherapy.

Rödel F, Steinhäuser K, Kreis NN, Friemel A, Martin D, Wieland U, Rave-Fränk M, Balermpas P, Fokas E, Louwen F, Rödel C, Yuan J.

Radiother Oncol. 2018 Feb;126(2):214-221. doi: 10.1016/j.radonc.2017.10.028. Epub 2017 Nov 6.

PMID:
29122359

Supplemental Content

Support Center